top of page

VOLUNTEER FOR RESEARCH

tincture icon.png

PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product

Clinical Trial

BAcKGROUND

This study is an FDA-approved clinical trial of a high-cannabidiol (CBD) sublingual product compared to placebo for 9 weeks in patients with chronic pain conditions.

STUDY DETAILS

Patients will be assessed at baseline (pre-treatment) and over 9 weeks of treatment with the study products on measures of clinical state, including pain and related symptoms, conventional medication use, and cognition. All patients will receive both the high-CBD study product and placebo at some point throughout the trial.

Please visit https://clinicaltrials.gov/study/NCT03984565 for more information

RECRUITMENT INFORMATION

Individuals with a chronic pain condition may be eligible.

We are currently recruiting interested individuals with chronic pain.

bottom of page